Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-22-016054

Options or other derivatives

  • President & Co-CEO acquired 1,159,420 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Chirag K. President & Co-CEO 2022-03-03 Grant or award · Performance-Based Restricted Stock Units +1,159,420 1,159,420 D
Loading xslF345X03/doc4.xml…